Skip to content

MEMO 3D SMD38Recalls & reported problems

Corcym Srl · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08022057013163), received between Sep 25, 2017 and Sep 25, 2017 — classified as 1 injury.

The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Patient-Device Incompatibility1

Patient problems

  • Heart Failure1
  • Mitral Regurgitation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 25, 2017Patient-Device Incompatibility; Patient-Device Incompatibility

    A MEMO 3D SIZE 38 WAS IMPLANTED ON (B)(6) 2017. ON (B)(6) 2017, DUE TO A SEVERE, PERSISTENT MR, THE PATIENT WAS RE-OPERATED. THE SURGEON REMOVED THE RING, PERFORMED A LEAFLET RECONSTRUCTION, AND IMPLANTED A NEW MEMO 3D SIZE 38. THE SURGERY WAS MINIMALLY INVASIVE. THE PATIENT REQUIRED ECMO TREATMENT DUE TO HEART FAILURE. ECMO WAS DISCONTINUED ON (B)(6) 2017, AND THE PATIENT IS NOW DOING WELL. THE MANUFACTURER WAS NOTIFIED OF THIS EVENT ON 29-AUG-2017.

    Patient problems: Heart Failure; Mitral Regurgitation

    MAUDE report 6891241 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page